Multiple Myeloma

Cost and Allocation of Scarce CAR-T Therapy for Patients With Multiple Myeloma

By

Tori Rodriguez, MA, LPC, AHC

Publish Date October 3, 2023

Researchers sought to determine the allocation and cost involved with CAR-T therapy for patients with multiple myeloma.

Higher Rate of Infections After AHCT for Multiple Myeloma Seen in India

By

Vicki Moore, PhD

Publish Date September 29, 2023

Researchers sought to determine rates of infections for patients with multiple myeloma receiving autologous transplantation in India compared to other countries.

Carfilzomib- and Pomalidomide-Based Regimens May Not Improve Outcomes in MM After Daratumumab

By

Jonathan Goodman, MPhil

Publish Date September 28, 2023

Researchers sought to determine whether carfilzomib- or pomalidomide-based therapeutic regimens would improve survival in MM following daratumumab.

PET Imaging After ASCT Identified Residual Disease in MM

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date September 27, 2023

Researchers sought to determine whether screening patients with MM after ASCT with FDG-PET would be able to identify patients with residual disease.

Postoperative Complications Common After Spinal Surgery for Multiple Myeloma

By

Jessica Nye, PhD

Publish Date September 26, 2023

Researchers evaluated data from 270 patients with MM undergoing spine surgery to determine complication and reoperation rates.